ER 阴性乳腺癌的临床试验
总计11742个结果
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia; Hospital... 和其他合作者完全的
-
Fudan University未知
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; iOMEDICO AG完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中癌症 | 转移性 | 胸部 | 三重否定 | 播散性肿瘤细胞美国
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity Inc主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)完全的骨转移性恶性肿瘤 | 三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7美国
-
Providence Health & ServicesInhibrx, Inc.尚未招聘
-
Institut CurieRoche Pharma AG; National Research Agency, France尚未招聘
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi Sankyo招聘中乳腺癌美国, 中国, 丹麦, 英国, 大韩民国, 加拿大, 德国, 意大利, 比利时, 西班牙, 日本, 法国, 台湾, 希腊, 巴西, 瑞典, 波多黎各
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
wang shusen招聘中
-
Cantargia ABSpanish Breast Cancer Research Group招聘中
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial Hospital招聘中
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘
-
Peking Union Medical College Hospital招聘中
-
Shengjing HospitalThe People's Hospital of Liaoning Province; Liaoning Tumor Hospital & Institute招聘中
-
Eileen ConnollyMerck Sharp & Dohme LLC招聘中
-
Washington University School of MedicineBristol-Myers Squibb主动,不招人
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.完全的
-
ImmunityBio, Inc.主动,不招人
-
Novartis Pharmaceuticals撤销
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC完全的
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZeneca主动,不招人
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
Georgetown UniversityBristol-Myers Squibb主动,不招人
-
University of Wisconsin, MadisonThe V Foundation for Cancer Research终止
-
Cedars-Sinai Medical CenterAstraZeneca撤销